OncoTherapy Science, Inc. (FRA:30O)

OncoTherapy Science Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,675	833	527	1,117	1,836	2,899
Cash & Short-Term Investments	1,675	833	527	1,117	1,836	2,899
Cash Growth	52.55%	58.06%	-52.82%	-39.16%	-36.67%	-38.49%
Accounts Receivable	44	98	35	123	399	152
Other Receivables	-	-	153	-	-	-
Receivables	44	98	188	123	399	152
Inventory	91	78	73	99	231	41
Other Current Assets	75	96	29	83	134	102
Total Current Assets	1,885	1,105	817	1,422	2,600	3,194
Property, Plant & Equipment	-	-	-	-	-	94
Long-Term Investments	49	49	49	89	84	74
Other Intangible Assets	-	-	-	-	-	4
Other Long-Term Assets	1	1	1	-	1	2
Total Assets	1,935	1,155	867	1,511	2,685	3,368
Current Income Taxes Payable	204	163	141	318	558	174
Other Current Liabilities	14	164	218	291	46	20
Total Current Liabilities	218	327	359	609	604	194
Long-Term Deferred Tax Liabilities	-	-	-	-	-	2
Other Long-Term Liabilities	72	100	155	48	102	97
Total Liabilities	290	427	514	657	706	293
Common Stock	786	50	50	789	789	50
Additional Paid-In Capital	28,252	27,516	26,322	24,793	24,793	24,054
Retained Earnings	-27,463	-26,908	-26,092	-24,804	-23,686	-21,114
Comprehensive Income & Other	70	70	73	76	83	85
Total Common Equity	1,645	728	353	854	1,979	3,075
Shareholders' Equity	1,645	728	353	854	1,979	3,075
Total Liabilities & Equity	1,935	1,155	867	1,511	2,685	3,368
Net Cash (Debt)	1,675	833	527	1,117	1,836	2,899
Net Cash Growth	52.55%	58.06%	-52.82%	-39.16%	-36.67%	-38.49%
Net Cash Per Share	5.92	3.19	2.48	5.80	9.79	16.44
Filing Date Shares Outstanding	338.64	277.64	239.34	206.64	192.64	176.33
Total Common Shares Outstanding	338.64	271.64	217.64	192.64	192.64	176.33
Working Capital	1,667	778	458	813	1,996	3,000
Book Value Per Share	4.86	2.68	1.62	4.43	10.27	17.44
Tangible Book Value	1,645	728	353	854	1,979	3,071
Tangible Book Value Per Share	4.86	2.68	1.62	4.43	10.27	17.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.